David S. Wishart

University of Alberta

Papers

3

Total Citations

48

H-Index

3

About

David S. Wishart is a pioneer in the field of metabolomics and bioinformatics, whose work has fundamentally transformed how researchers and clinicians analyze small molecules in biological systems. His key research areas include metabolomics, magnetic resonance diagnostics, and the development of comprehensive bioinformatics databases. Wishart’s major contributions include the creation of DrugBank, a richly annotated, freely accessible database that has become an essential resource for pharmaceutical research and drug discovery, bridging the gap between genomics and clinical medicine. He also developed the concept of magnetic resonance diagnostics (MRD), a high-throughput NMR-based technology for rapid metabolite identification in biofluids like blood and urine, enabling faster clinical diagnostics. More recently, his team introduced the Open SprayBot, a high-throughput paper spray mass spectrometry platform designed for cost-effective, scalable newborn disease screening. With over 35,000 citations across his body of work, Wishart’s impact is profound—his databases and analytical platforms are used globally by researchers and clinicians. Notably, DrugBank alone has been cited over 7,000 times, underscoring its centrality to modern drug development. Wishart’s work continues to drive the transition of life sciences into a data-driven discipline.

Research Focus

Key Achievements

3
H-Index
3
Papers
48
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
Magnetic Resonance Diagnostics: A New Technology for High-Throughput Clinical Diagnostics
35 citations · 2001
📈 Most Prolific Year: 2001 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: University of Alberta

Top Papers

  1. 1
  2. 2
    DrugBank
    7 citations · 2012
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 17 days ago